Cargando…
Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
The strong non-covalent interaction between biotin and streptavidin places streptavidin-based assays, used by many laboratories, at an increased risk of interference by biotin. At present, a few manufacturers have developed fully automated anti-biotin interference methods, although compared with man...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324022/ https://www.ncbi.nlm.nih.gov/pubmed/35885633 http://dx.doi.org/10.3390/diagnostics12071729 |
_version_ | 1784756705143291904 |
---|---|
author | Liu, Dong Gebreab, Yacob Berhane Hu, Jian Zhou, Lili Zhang, Ning Tong, Hui Chen, Bin Wang, Xiaoqin |
author_facet | Liu, Dong Gebreab, Yacob Berhane Hu, Jian Zhou, Lili Zhang, Ning Tong, Hui Chen, Bin Wang, Xiaoqin |
author_sort | Liu, Dong |
collection | PubMed |
description | The strong non-covalent interaction between biotin and streptavidin places streptavidin-based assays, used by many laboratories, at an increased risk of interference by biotin. At present, a few manufacturers have developed fully automated anti-biotin interference methods, although compared with many detection platforms, these remain insufficient. Additionally, there is a need for more methods that can achieve fully automated anti-biotin interference. We sought to develop and evaluate a new biotin interference-resisting method based on a biotin-streptavidin chemiluminescence immunoassay. Streptavidin-coated magnetic microparticles (M) of different concentrations were prepared and tested for their biotin-resistance capabilities in an automated setting (Cobas e 601). The precision, accuracy, and detection capability were also assessed. Higher concentrations of M were found to have a stronger ability to resist biotin interference. A 2.16 mg/mL concentration of M was able to resist 500 ng/mL of biotin in samples while simultaneously having a relatively weak shielding effect on the optical signals. Moreover, the total precision and accuracy of this method, designated as M3, met acceptable standards. M3 has an improved ability to resist biotin interference, can achieve full automation, and its detection performance can meet the general laboratory quality requirements. |
format | Online Article Text |
id | pubmed-9324022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93240222022-07-27 Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays Liu, Dong Gebreab, Yacob Berhane Hu, Jian Zhou, Lili Zhang, Ning Tong, Hui Chen, Bin Wang, Xiaoqin Diagnostics (Basel) Article The strong non-covalent interaction between biotin and streptavidin places streptavidin-based assays, used by many laboratories, at an increased risk of interference by biotin. At present, a few manufacturers have developed fully automated anti-biotin interference methods, although compared with many detection platforms, these remain insufficient. Additionally, there is a need for more methods that can achieve fully automated anti-biotin interference. We sought to develop and evaluate a new biotin interference-resisting method based on a biotin-streptavidin chemiluminescence immunoassay. Streptavidin-coated magnetic microparticles (M) of different concentrations were prepared and tested for their biotin-resistance capabilities in an automated setting (Cobas e 601). The precision, accuracy, and detection capability were also assessed. Higher concentrations of M were found to have a stronger ability to resist biotin interference. A 2.16 mg/mL concentration of M was able to resist 500 ng/mL of biotin in samples while simultaneously having a relatively weak shielding effect on the optical signals. Moreover, the total precision and accuracy of this method, designated as M3, met acceptable standards. M3 has an improved ability to resist biotin interference, can achieve full automation, and its detection performance can meet the general laboratory quality requirements. MDPI 2022-07-16 /pmc/articles/PMC9324022/ /pubmed/35885633 http://dx.doi.org/10.3390/diagnostics12071729 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Dong Gebreab, Yacob Berhane Hu, Jian Zhou, Lili Zhang, Ning Tong, Hui Chen, Bin Wang, Xiaoqin Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays |
title | Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays |
title_full | Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays |
title_fullStr | Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays |
title_full_unstemmed | Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays |
title_short | Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays |
title_sort | development and evaluation of an anti-biotin interference method in biotin-streptavidin immunoassays |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324022/ https://www.ncbi.nlm.nih.gov/pubmed/35885633 http://dx.doi.org/10.3390/diagnostics12071729 |
work_keys_str_mv | AT liudong developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays AT gebreabyacobberhane developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays AT hujian developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays AT zhoulili developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays AT zhangning developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays AT tonghui developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays AT chenbin developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays AT wangxiaoqin developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays |